[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Prescription and Over-the-Counter Drug Product List - 22nd Edition
Cumulative Supplement Number 12: December 2002

[Prescription - OTC]

NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section CUMULATIVE SUPPLEMENT LEGEND.



ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

         ACARBOSE
          TABLET; ORAL
            PRECOSE
>D>           BAYER                   25MG                                     N20482 004  MAY 29, 1997  DEC  CAHN
>D>                                   50MG                                     N20482 001  SEP 06, 1995  DEC  CAHN
>D>       +                           100MG                                    N20482 002  SEP 06, 1995  DEC  CAHN
>A>           BAYER PHARMS            25MG                                     N20482 004  MAY 29, 1997  DEC  CAHN
>A>                                   50MG                                     N20482 001  SEP 06, 1995  DEC  CAHN
>A>       +                           100MG                                    N20482 002  SEP 06, 1995  DEC  CAHN

        ACYCLOVIR
>A>       CREAM; TOPICAL
>A>         ZOVIRAX
>A>       +   GLAXOSMITHKLINE         5%                                       N21478 001  DEC 30, 2002  DEC  NEWA

        AMANTADINE HYDROCHLORIDE
          TABLET; ORAL
>A>         AMANTADINE HCL
>A>   AB      USL PHARMA              100MG                                    N76186 001  DEC 16, 2002  DEC  NEWA
            SYMMETREL
>D>       +   ENDO PHARMS             100MG                                    N18101 001                DEC  CFTG
>A>   AB  +                           100MG                                    N18101 001                DEC  CFTG

        AMIODARONE HYDROCHLORIDE
          INJECTABLE; INJECTION
            AMIODARONE HCL
>A>   AP      BIONICHE (CANADA)       50MG/ML                                  N76217 001  OCT 15, 2002  DEC  CAHN
>D>   AP      PHARMAFORCE             50MG/ML                                  N76217 001  OCT 15, 2002  DEC  CAHN
          TABLET; ORAL
>A>       +   TARO                    100MG                                    N75424 002  DEC 18, 2002  DEC  NEWA

         AMOXICILLIN
          FOR SUSPENSION; ORAL
            AMOXICILLIN
>A>   AB      TEVA                    200MG/5ML                                N65119 001  DEC 04, 2002  DEC  NEWA
>A>   AB                              400MG/5ML                                N65119 002  DEC 04, 2002  DEC  NEWA

        AMOXICILLIN; CLAVULANATE POTASSIUM
          FOR SUSPENSION; ORAL
            AMOXICILLIN AND CLAVULANATE POTASSIUM
>A>   AB      LEK SVCS                200MG/5ML;EQ 28.5MG BASE/5ML             N65098 001  DEC 16, 2002  DEC  NEWA
>A>   AB                              400MG/5ML;EQ 57MG BASE/5ML               N65098 002  DEC 16, 2002  DEC  NEWA


        AZELAIC ACID
>A>       GEL; TOPICAL
>A>         FINACEA
>A>       +   BERLEX                  15%                                      N21470 001  DEC 24, 2002  DEC  NEWA

        BACITRACIN
          INJECTABLE; INJECTION
            BACITRACIN
>A>   AP      AM PHARM PARTNERS       50,000 UNITS/VIAL                        N65116 001  DEC 03, 2002  DEC  NEWA

        BUTORPHANOL TARTRATE
          SPRAY, METERED; NASAL
            BUTORPHANOL TARTRATE
>A>   AB      NOVEX                   1MG/SPRAY                                N75499 001  DEC 04, 2002  DEC  NEWA

        CALCITRIOL
          INJECTABLE; INJECTION
            CALCIJEX
>D>       +   ABBOTT                  0.001MG/ML                               N18874 001  SEP 25, 1986  DEC  CFTG
>A>   AP  +                           0.001MG/ML                               N18874 001  SEP 25, 1986  DEC  CFTG
>D>       +                           0.002MG/ML                               N18874 002  SEP 25, 1986  DEC  CFTG
>A>   AP  +                           0.002MG/ML                               N18874 002  SEP 25, 1986  DEC  CFTG
>A>         CALCITRIOL
>A>   AP      AM PHARM PARTNERS       0.001MG/ML                               N75836 001  DEC 31, 2002  DEC  NEWA
>A>   AP                              0.002MG/ML                               N75836 002  DEC 31, 2002  DEC  NEWA

>A>     CALCIUM CHLORIDE; ICODEXTRIN; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
>A>       SOLUTION; INTRAPERITONEAL
>A>         EXTRANEAL
>A>       +   BAXTER HLTHCARE         25.7MG/100ML;7.5GM/100ML;5.08MG/100
                                      ML;535MG/100ML;448MG/100ML               N21321 001  DEC 20, 2002  DEC  NEWA

        CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
>A>       TABLET, EXTENDED RELEASE; ORAL
>A>         CIPRO XR
>A>       +   BAYER PHARMS            212.6MG;EQ 287.5MG BASE                  N21473 001  DEC 13, 2002  DEC  NEWA

        CLONIDINE
          FILM, EXTENDED RELEASE; TRANSDERMAL
            CATAPRES-TTS-1
>D>       +   BOEHRINGER INGELHEIM    0.1MG/24HR                               N18891 001  OCT 10, 1984  DEC  CRLD
>A>                                   0.1MG/24HR                               N18891 001  OCT 10, 1984  DEC  CRLD

            CATAPRES-TTS-2
>D>       +   BOEHRINGER INGELHEIM    0.2MG/24HR                               N18891 002  OCT 10, 1984  DEC  CRLD
>A>                                   0.2MG/24HR                               N18891 002  OCT 10, 1984  DEC  CRLD

        CYCLOSPORINE
>A>       EMULSION; OPHTHALMIC
>A>         RESTASIS
>A>       +   ALLERGAN                0.05%                                    N21023 001  DEC 23, 2002  DEC  NEWA

        DIFLORASONE DIACETATE
          CREAM; TOPICAL
            DIFLORASONE DIACETATE
>D>   AB1     ALTANA                  0.05%                                    N75187 001  MAR 30, 2098  DEC  CTEC
>A>   AB1                             0.05%                                    N75187 001  MAR 30, 2098  DEC  CTEC
>A>   AB2                             0.05%                                    N76263 001  DEC 20, 2002  DEC  NEWA
>D>   AB      TARO                    0.05%                                    N75508 001  APR 24, 2000  DEC  CTEC
>A>   AB1                             0.05%                                    N75508 001  APR 24, 2000  DEC  CTEC

            FLORONE E
>D>   BX  +   PHARMACIA AND UPJOHN    0.05%                                    N19259 001  AUG 28, 2085  DEC  CTEC
>A>   AB2 +                           0.05%                                    N19259 001  AUG 28, 2085  DEC  CTEC
>D>   AB  +   DERMIK LABS             0.05%                                    N20205 001  NOV 20, 2092  DEC  CTEC
>A>   AB1 +                           0.05%                                    N20205 001  NOV 20, 2092  DEC  CTEC

        DILTIAZEM HYDROCHLORIDE
          INJECTABLE; INJECTION
            DILTIAZEM HCL
>A>   AP      ABBOTT                  100MG/VIAL                               N75853 001  DEC 17, 2002  DEC  NEWA

        DISULFIRAM
          TABLET; ORAL
            ANTABUSE
>D>           ODYSSEY PHARMS          250MG                                    N88482 001  DEC 08, 1983  DEC  CRLD
>A>       +                           250MG                                    N88482 001  DEC 08, 1983  DEC  CRLD
>D>       +                           500MG                                    N88483 001  DEC 08, 1983  DEC  DISC
>A>         @                         500MG                                    N88483 001  DEC 08, 1983  DEC  DISC

        DOXYCYCLINE
          TABLET; ORAL
            DOXYCYCLINE
>A>           PAR PHARM               EQ 75MG BASE                             N65070 003  DEC 30, 2002  DEC  NEWA

        EDETATE DISODIUM
          INJECTABLE; INJECTION
            EDETATE DISODIUM
>A>   AP      BIONICHE (CANADA)       150MG/ML                                 N40437 001  JUL 09, 2002  DEC  CAHN
>D>   AP      PHARMAFORCE             150MG/ML                                 N40437 001  JUL 09, 2002  DEC  CAHN

>A>     ELETRIPTAN HYDROBROMIDE
>A>       TABLET; ORAL
>A>         RELPAX
>A>           PFIZER                  EQ 20MG BASE                             N21016 001  DEC 26, 2002  DEC  NEWA
>A>       +   PFIZER IRELAND          EQ 40MG BASE                             N21016 002  DEC 26, 2002  DEC  NEWA

        ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE
          INJECTABLE; INJECTION
            DEPO-TESTADIOL
>D>   AO  +   PHARMACIA AND UPJOHN    2MG/ML;50MG/ML                           N17968 001                DEC  CTEC
>A>       +                           2MG/ML;50MG/ML                           N17968 001                DEC  CTEC
>D>         TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE
>D>   AO      STERIS                  2MG/ML;50MG/ML                           N85603 001  MAR 13, 1986  DEC  DISC
>A>         @                         2MG/ML;50MG/ML                           N85603 001  MAR 13, 1986  DEC  DISC

>D>     ESTRADIOL VALERATE; TESTOSTERONE ENANTHATE
>D>       INJECTABLE; INJECTION
>D>         DITATE-DS
>D>       +   SAVAGE LABS             8MG/ML;180MG/ML                          N86423 001                DEC  DISC
>A>         @                         8MG/ML;180MG/ML                          N86423 001                DEC  DISC
>D>         TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE
>D>       +   STERIS                  4MG/ML;90MG/ML                           N85865 001                DEC  DISC
>A>         @                         4MG/ML;90MG/ML                           N85865 001                DEC  DISC

        ETHINYL ESTRADIOL; NORGESTIMATE
          TABLET; ORAL-28
            ORTHO TRI-CYCLEN
>D>       +   ORTHO MCNEIL PHARM      0.035MG,0.035MG,0.035MG;0.18MG,0.21
                                      5MG,0.25MG                               N19697 001  JUL 03, 1992  DEC  CFTG
>A>   AB  +                           0.035MG,0.035MG,0.035MG;0.18MG,0.21
                                      5MG,0.25MG                               N19697 001  JUL 03, 1992  DEC  CFTG

            TRI-SPRINTEC
>A>   AB      BARR                    0.035MG;0.18MG                           N75808 001  DEC 18, 2002  DEC  NEWA

        ETODOLAC
          TABLET; ORAL
            ETODOLAC
>A>   AB      APOTEX                  400MG                                    N76004 001  DEC 03, 2002  DEC  NEWA
>A>   AB                              500MG                                    N76004 002  DEC 03, 2002  DEC  NEWA

        GALLIUM NITRATE
          INJECTABLE; INJECTION
            GANITE
>D>         @ GENTA                   25MG/ML                                  N19961 002  JAN 17, 1991  DEC  CMFD
>A>       +                           25MG/ML                                  N19961 002  JAN 17, 1991  DEC  CMFD

        GATIFLOXACIN
          INJECTABLE; INJECTION
            TEQUIN
>A>       +   BRISTOL MYERS SQUIBB    EQ 2MG /ML(200MG/100ML)                  N21062 001  DEC 17, 1999  DEC  CPOT
>A>       +                           EQ 2MG /ML(400MG/200ML)                  N21062 002  DEC 17, 1999  DEC  CPOT
>A>                                   EQ 10MG /ML(200MG)                       N21062 003  DEC 17, 1999  DEC  NEWA
>A>       +                           EQ 10MG /ML(400MG)                       N21062 004  DEC 17, 1999  DEC  NEWA
>D>       +                           EQ 2MG /ML(200MG/100ML)                  N21062 001  DEC 17, 1999  DEC  CPOT
>D>       +                           EQ 2MG /ML(400MG/200ML)                  N21062 002  DEC 17, 1999  DEC  CPOT

        HYDROFLUMETHIAZIDE
          TABLET; ORAL
            SALURON
>D>   AB  +   SHIRE LABS              50MG                                     N11949 001                DEC  CAHN
>A>   AB  +                           50MG                                     N11949 001                DEC  CAHN

        HYDROFLUMETHIAZIDE; RESERPINE
          TABLET; ORAL
            SALUTENSIN
>D>       +   SHIRE LABS              50MG;0.125MG                             N12359 003                DEC  CAHN
>A>       +                           50MG;0.125MG                             N12359 003                DEC  CAHN
            SALUTENSIN-DEMI
>D>         @ SHIRE LABS              25MG;0.125MG                             N12359 004                DEC  CAHN
>A>         @                         25MG;0.125MG                             N12359 004                DEC  CAHN

        ISOTRETINOIN
          CAPSULE; ORAL
            ISOTRETINOIN
>A>   AB      RANBAXY                 10MG                                     N76041 001  DEC 24, 2002  DEC  NEWA
>A>   AB                              20MG                                     N76041 002  DEC 24, 2002  DEC  NEWA
>A>   AB                              40MG                                     N76041 003  DEC 24, 2002  DEC  NEWA

        KANAMYCIN SULFATE
          INJECTABLE; INJECTION
>A>         KANAMYCIN
>A>   AP      AM PHARM PARTNERS       EQ 500MG BASE/2ML                        N65111 001  DEC 17, 2002  DEC  NEWA
>A>   AP                              EQ 1GM BASE/3ML                          N65111 002  DEC 17, 2002  DEC  NEWA
            KANTREX
>D>       +   APOTHECON               EQ 500MG BASE/2ML                        N61901 001                DEC  CFTG
>A>   AP  +                           EQ 500MG BASE/2ML                        N61901 001                DEC  CFTG
>D>       +                           EQ 1GM BASE/3ML                          N61901 002                DEC  CFTG
>A>   AP  +                           EQ 1GM BASE/3ML                          N61901 002                DEC  CFTG

        KETOCONAZOLE
          CREAM; TOPICAL
            KETOZOLE
>A>   AB      TARO                    2%                                       N75638 001  DEC 18, 2002  DEC  NEWA

        LEUCOVORIN CALCIUM
          FOR SOLUTION; ORAL
            LEUCOVORIN CALCIUM
>D>         @ IMMUNEX                 EQ 60MG BASE/VIAL                        N08107 003  JAN 30, 1987  DEC  CAHN
>A>         @ XANODYNE PHARM          EQ 60MG BASE/VIAL                        N08107 003  JAN 30, 1987  DEC  CAHN
          INJECTABLE; INJECTION
>D>         @ IMMUNEX                 EQ 3MG BASE/ML                           N08107 001                DEC  CAHN
>D>   AP  +                           EQ 50MG BASE/VIAL                        N08107 002                DEC  CAHN
>D>   AP  +                           EQ 100MG BASE/VIAL                       N08107 004  MAY 23, 1988  DEC  CAHN
>D>   AP  +                           EQ 350MG BASE/VIAL                       N08107 005  APR 05, 1989  DEC  CAHN
>A>         @ XANODYNE PHARM          EQ 3MG BASE/ML                           N08107 001                DEC  CAHN
>A>   AP  +                           EQ 50MG BASE/VIAL                        N08107 002                DEC  CAHN
>A>   AP  +                           EQ 100MG BASE/VIAL                       N08107 004  MAY 23, 1988  DEC  CAHN
>A>   AP  +                           EQ 350MG BASE/VIAL                       N08107 005  APR 05, 1989  DEC  CAHN

        METFORMIN HYDROCHLORIDE
          TABLET; ORAL
            METFORMIN HCL
>A>   AB      TEVA                    500MG                                    N76328 001  DEC 16, 2002  DEC  NEWA
>A>   AB                              850MG                                    N76328 002  DEC 16, 2002  DEC  NEWA
>A>   AB                              1GM                                      N76328 003  DEC 16, 2002  DEC  NEWA

        METHYLPHENIDATE HYDROCHLORIDE
>A>       SOLUTION; ORAL
>A>         METHYLIN
>A>       +   MALLINCKRODT BAKER      5MG/5ML                                  N21419 001  DEC 19, 2002  DEC  NEWA
>A>       +                           10MG/5ML                                 N21419 002  DEC 19, 2002  DEC  NEWA

        MITOXANTRONE HYDROCHLORIDE
          INJECTABLE; INJECTION
            NOVANTRONE
>D>       +   IMMUNEX                 EQ 2MG BASE/ML                           N19297 001  DEC 23, 1987  DEC  CAHN
>A>       +   SERONO INC              EQ 2MG BASE/ML                           N19297 001  DEC 23, 1987  DEC  CAHN

        MORICIZINE HYDROCHLORIDE
          TABLET; ORAL
            ETHMOZINE
>D>           SHIRE LABS              200MG                                    N19753 001  JUN 19, 1990  DEC  CAHN
>A>                                   200MG                                    N19753 001  JUN 19, 1990  DEC  CAHN
>D>                                   250MG                                    N19753 002  JUN 19, 1990  DEC  CAHN
>A>                                   250MG                                    N19753 002  JUN 19, 1990  DEC  CAHN
>D>       +                           300MG                                    N19753 003  JUN 19, 1990  DEC  CAHN
>A>       +                           300MG                                    N19753 003  JUN 19, 1990  DEC  CAHN

        MUPIROCIN
          OINTMENT; TOPICAL
            MUPIROCIN
>A>           CLAY PARK LABS          2%                                       N50788 001  DEC 04, 2002  DEC  NEWA

        OMEPRAZOLE
          CAPSULE, DELAYED REL PELLETS; ORAL
            OMEPRAZOLE
>A>   AB      EON                     10MG                                     N75791 001  DEC 23, 2002  DEC  NEWA
>A>   AB                              20MG                                     N75791 002  DEC 23, 2002  DEC  NEWA

        PREDNISOLONE SODIUM PHOSPHATE
          SOLUTION; ORAL
            PREDNISOLONE SODIUM PHOSPHATE
>A>   AA      PHARM ASSOC             EQ 5MG BASE/5ML                          N76123 001  DEC 23, 2002  DEC  NEWA
>A>   AA      WE PHARMS               EQ 5MG BASE/5ML                          N75181 001  DEC 23, 2002  DEC  NEWA

        PROGESTERONE
          GEL; VAGINAL
            CRINONE
>D>       +   COLUMBIA RES LABS       8%                                       N20756 001  MAY 13, 1997  DEC  CMS2
>A>                                   8%                                       N20756 001  MAY 13, 1997  DEC  CMS2

        PYRIDOSTIGMINE BROMIDE
          TABLET; ORAL
            MESTINON
>D>       +   ICN                     60MG                                     N09829 002                DEC  CFTG
>A>   AB  +                           60MG                                     N09829 002                DEC  CFTG
>A>         PYRIDOSTIGMINE BROMIDE
>A>   AB      COREPHARMA              60MG                                     N40457 001  DEC 26, 2002  DEC  NEWA

        RIBAVIRIN
>A>       TABLET; ORAL
>A>         COPEGUS
>A>       +   ROCHE                   200MG                                    N21511 001  DEC 03, 2002  DEC  NEWA

        STAVUDINE
>A>       CAPSULE, EXTENDED RELEASE; ORAL
>A>         ZERIT XR
>A>           BRISTOL MYERS SQUIBB    37.5MG                                   N21453 001  DEC 31, 2002  DEC  NEWA
>A>                                   50MG                                     N21453 002  DEC 31, 2002  DEC  NEWA
>A>                                   75MG                                     N21453 003  DEC 31, 2002  DEC  NEWA
>A>       +                           100MG                                    N21453 004  DEC 31, 2002  DEC  NEWA

        TERBINAFINE
          GEL; TOPICAL
            LAMISIL
>D>         @ NOVARTIS                1%                                       N20846 001  APR 29, 1998  DEC  CAHN
>A>         @                         1%                                       N20846 001  APR 29, 1998  DEC  CAHN

        TERBINAFINE HYDROCHLORIDE
          SOLUTION; TOPICAL
>D>       +   NOVARTIS                1%                                       N20749 001  OCT 17, 1997  DEC  CAHN
>A>       +                           1%                                       N20749 001  OCT 17, 1997  DEC  CAHN

        TERIPARATIDE ACETATE
          INJECTABLE; SUBCUTANEOUS
            FORTEO
>D>       +   LILLY                   EQ 0.75MG 3ML(0.25MG/ML)                 N21318 001  NOV 26, 2002  DEC  CTNA
>A>       +                           EQ 0.75MG 3ML(0.25MG/ML)                 N21318 001  NOV 26, 2002  DEC  CTNA

        VINCRISTINE SULFATE
          INJECTABLE; INJECTION
            VINCRISTINE SULFATE
>A>       +   AM PHARM PARTNERS       1MG/ML                                   N76296 001  DEC 20, 2002  DEC  NEWA


 

ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST



>A>     CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
>A>       TABLET; ORAL
>A>         ADVIL ALLERGY SINUS
>A>       +   WYETH CONS              2MG;200MG;30MG                           N21441 001  DEC 19, 2002  DEC  NEWA

>A>     LORATADINE
>A>       TABLET, ORALLY DISINTEGRATING; ORAL
>A>         ALAVERT
>A>       +   WYETH CONS              10MG                                     N21375 001  DEC 19, 2002  DEC  NEWA

        POTASSIUM IODIDE
          TABLET; ORAL
            THYROSAFE
>D>           R R REGISTRATIONS       65MG                                     N76350 001  SEP 10, 2002  DEC  CRLD
>A>       +                           65MG                                     N76350 001  SEP 10, 2002  DEC  CRLD

 

Last update: July 15, 2005

horizonal rule